Aron S. Bode
Maastricht University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Aron S. Bode.
Journal of Vascular Surgery | 2009
Jan H. M. Tordoir; Aron S. Bode; Noud Peppelenbosch; Frank M. van der Sande; Michiel W. de Haan
INTRODUCTION Endovascular and surgical strategies have been used to manage patients with thrombosed vascular access for hemodialysis. We analyzed the evidence to see whether endovascular or surgical treatment has the best outcome in terms of primary success rate and long-term patency. METHODS We performed a systematic literature search of endovascular and surgical repair of thrombosed hemodialysis vascular access. The analysis included meta-analysis, randomized, and population-based studies of thrombosed arteriovenous fistulae and grafts. RESULTS One meta-analysis and eight randomized studies on the treatment of arteriovenous graft thrombosis were identified. Studies conducted before 2002 demonstrated a significantly better primary success rate and primary and secondary patencies of surgical thrombectomy vs endovascular intervention. After 2002, similar results of both techniques have been reported. Only population-based studies on the treatment of thrombosed autogenous arteriovenous fistulae have been published, showing similar outcome of surgical and endovascular intervention in terms of primary success. The long-term primary and secondary patencies are slightly better for surgical treatment, but this concerns only forearm fistulae. CONCLUSIONS The outcome of endovascular and surgical intervention for thrombosed vascular access is comparable, in particular for thrombosed prosthetic grafts. Surgical treatment of autogenous arteriovenous fistulae is likely to have benefit compared with endovascular means. Definitive randomized trials are needed to provide the level 1 evidence to resolve this latter issue.
Medical Engineering & Physics | 2012
Wouter Huberts; Aron S. Bode; Wilco Kroon; Rn Planken; Jhm Jan Tordoir; van de Fn Frans Vosse; Emh Mariëlle Bosboom
The preferred vascular access for hemodialysis is an autologous arteriovenous fistula (AVF) in the arm: a surgically created connection between an artery and vein. The surgeon selects the AVF location based on experience and preoperative diagnostics. However, 20-50% of all lower arm AVFs are hampered by a too low access flow, whereas complications associated with too high flows are observed in 20% of all upper arm AVFs. We hypothesize that a pulse wave propagation model fed by patient-specific data has the ability to assist the surgeon in selecting the optimal AVF configuration by predicting direct postoperative flow. Previously, a 1D wave propagation model (spectral elements) was developed in which an approximated velocity profile was assumed based on boundary layer theory. In this study, we derived a distributed lumped parameter implementation of the pulse wave propagation model. The elements of the electrical analog for a segment are based on the approximated velocity profiles and dependent on the Womersley number. We present the application of the lumped parameter pulse wave propagation model to vascular access surgery and show how a patient-specific model is able to predict the hemodynamical impact of AVF creation and might assist in vascular access planning. The lumped parameter pulse wave propagation model was able to select the same AVF configuration as an experienced surgeon in nine out of ten patients. In addition, in six out of ten patients predicted postoperative flows were in the same order of magnitude as measured postoperative flows. Future research should quantify uncertainty in model predictions and measurements.
Kidney International | 2013
Anna Caroli; Simone Manini; Luca Antiga; Katia Passera; Bogdan Ene-Iordache; Stefano Rota; Giuseppe Remuzzi; Aron S. Bode; Jaap Leermakers; Frans N. van de Vosse; Raymond Vanholder; Marko Malovrh; Jan H. M. Tordoir; Andrea Remuzzi
Vascular access dysfunction is one of the main causes of morbidity and hospitalization in hemodialysis patients. This major clinical problem points out the need for prediction of hemodynamic changes induced by vascular access surgery. Here we reviewed the potential of a patient-specific computational vascular network model that includes vessel wall remodeling to predict blood flow change within 6 weeks after surgery for different arteriovenous fistula configurations. For model validation, we performed a multicenter, prospective clinical study to collect longitudinal data on arm vasculature before and after surgery. Sixty-three patients with newly created arteriovenous fistula were included in the validation data set and divided into four groups based on fistula configuration. Predicted brachial artery blood flow volumes 40 days after surgery had a significantly high correlation with measured values. Deviation of predicted from measured brachial artery blood flow averaged 3% with a root mean squared error of 19.5%, showing that the computational tool reliably predicted patient-specific blood flow increase resulting from vascular access surgery and subsequent vascular adaptation. This innovative approach may help the surgeon to plan the most appropriate fistula configuration to optimize access blood flow for hemodialysis, potentially reducing the incidence of vascular access dysfunctions and the need of patient hospitalization.
European Journal of Vascular and Endovascular Surgery | 2013
Jaap Leermakers; Aron S. Bode; A. Vaidya; F.M. van der Sande; S.M.A.A. Evers; Jan H. M. Tordoir
BACKGROUND The use of an arteriovenous fistula (AVF) for haemodialysis treatment may be associated with a high early failure rate, but usually good long-term patency, while using an arteriovenous graft (AVG) yields a lower early failure rate with worse long-term patency. The aim of this study was to calculate and compare the costs and outcome of AVF and AVG surgery in terms of early and long-term patencies. METHODS A decision tree and a Markov model were constructed to calculate costs and performance of AVFs and AVGs. The model was populated with a retrospective cohort of HD patients receiving their first VA. The outcomes were determined probabilistically with a 5-year follow-up. RESULTS AVFs were usable for a mean (95% CI) of 28.5 months (24.6-32.5 months), while AVGs showed a patency of 25.5 months (20.0-31.2 months). The use of AVFs was the dominant type of VA and € 631 could be saved per patient/per month patency compared to AVG use. Regardless of the willingness to pay, the use of AVFs yielded a higher probability of being cost-effective compared to AVGs. CONCLUSIONS AVFs are more cost-effective than AVGs. Nonetheless, early failure rates significantly influence AVF performance and initiatives to reduce early failure can improve its cost-effectiveness.
Journal of Vascular Access | 2011
Aron S. Bode; Anna Caroli; Wouter Huberts; R. Nils Planken; Luca Antiga; Marielle Bosboom; Andrea Remuzzi; Jan H. M. Tordoir
Despite clinical guidelines and the possibility of diagnostic vascular imaging, creation and maintenance of a vascular access (VA) remains problematic: avoiding short- and long-term VA dysfunction is challenging. Although prognostic factors for VA dysfunction have been identified in previous studies, their potential interplay at a systemic level is disregarded. Consideration of multiple prognostic patient specific factors and their complex interaction using dedicated computational modeling tools might improve outcome after VA creation by enabling a better selection of VA configuration. These computational modeling tools are developed and validated in the ARCH project: a joint initiative of four medical centers and three industrial partners (FP7-ICT-224390). This paper reports the rationale behind computational modeling and presents the clinical study protocol designed for calibrating and validating these modeling tools. The clinical study is based on the pre-operative collection of structural and functional data at a vascular level, as well as a VA functional evaluation during the follow-up period. The strategy adopted to perform the study and for data collection is also described here.
PLOS ONE | 2012
Aron S. Bode; Wouter Huberts; E. Marielle H. Bosboom; Wilco Kroon; Wim van der Linden; R. Nils Planken; Frans N. van de Vosse; Jan H. M. Tordoir
Introduction Inadequate flow enhancement on the one hand, and excessive flow enhancement on the other hand, remain frequent complications of arteriovenous fistula (AVF) creation, and hamper hemodialysis therapy in patients with end-stage renal disease. In an effort to reduce these, a patient-specific computational model, capable of predicting postoperative flow, has been developed. The purpose of this study was to determine the accuracy of the patient-specific model and to investigate its feasibility to support decision-making in AVF surgery. Methods Patient-specific pulse wave propagation models were created for 25 patients awaiting AVF creation. Model input parameters were obtained from clinical measurements and literature. For every patient, a radiocephalic AVF, a brachiocephalic AVF, and a brachiobasilic AVF configuration were simulated and analyzed for their postoperative flow. The most distal configuration with a predicted flow between 400 and 1500 ml/min was considered the preferred location for AVF surgery. The suggestion of the model was compared to the choice of an experienced vascular surgeon. Furthermore, predicted flows were compared to measured postoperative flows. Results Taken into account the confidence interval (25th and 75th percentile interval), overlap between predicted and measured postoperative flows was observed in 70% of the patients. Differentiation between upper and lower arm configuration was similar in 76% of the patients, whereas discrimination between two upper arm AVF configurations was more difficult. In 3 patients the surgeon created an upper arm AVF, while model based predictions allowed for lower arm AVF creation, thereby preserving proximal vessels. In one patient early thrombosis in a radiocephalic AVF was observed which might have been indicated by the low predicted postoperative flow. Conclusions Postoperative flow can be predicted relatively accurately for multiple AVF configurations by using computational modeling. This model may therefore be considered a valuable additional tool in the preoperative work-up of patients awaiting AVF creation.
European Journal of Vascular and Endovascular Surgery | 2012
Aron S. Bode; Rn Planken; Mag Maarten Merkx; F.M. van der Sande; L Geerts; Jhm Jan Tordoir; Tim Leiner
OBJECTIVES Preoperative mapping of arterial and venous anatomy helps to prevent postoperative complications after vascular access creation. The use of gadolinium in contrast-enhanced (CE) magnetic resonance angiography (MRA) has been linked to nephrogenic systemic fibrosis in patients with end-stage renal disease (ESRD). The purpose of this study was to evaluate non-contrast-enhanced (NCE) MRA for assessment of upper extremity and central vasculature and to compare it with CE-MRA. METHODS NCE and CE-MRA images were acquired in 10 healthy volunteers and 15 patients with ESRD. In each data set, two observers analysed 11 arterial and 16 venous segments with regard to image quality (0-4), presence of artefacts (0-2) and vessel-to-background ratio. RESULTS More arterial segments were depicted using CE-MRA compared to NCE-MRA (99% vs. 96%, p = 0.001) with mean image quality of 3.80 vs. 2.68, (p < 0.001) and mean vessel-to-background ratio of 6.47 vs. 4.14 (p < 0.001). Ninety-one percent of the venous segments were portrayed using NCE-MRA vs. 80% using CE-MRA (p < 0.001). Mean image quality and vessel-to-background ratio were 2.41 vs. 2.21 (p = 0.140) and 5.13 vs. 3.88 (p < 0.001), respectively. CONCLUSIONS Although arterial image quality and vessel-to-background ratios were lower, NCE-MRA is considered a feasible alternative to CE-MRA in patients with ESRD who need imaging of the upper extremity and central vasculature prior to dialysis access creation.
European Journal of Vascular and Endovascular Surgery | 2015
Jan H. M. Tordoir; Aron S. Bode; M.M. van Loon
BACKGROUND Adequate functioning vascular access is the key to successful hemodialysis. The use of an autologous arteriovenous fistula (AVF) is advised because of good long-term patency and a low incidence of complications. However, the number of patients with AVFs is declining because of the change in the demography of the dialysis population, with increasing numbers of very old patients with multiple comorbidities. METHODS In this vignette an elderly patient is described with calcified distal arteries and a small cephalic vein who is referred at a late stage for access creation. The results and performance of different types of vascular access (AVF; arteriovenous graft; central vein catheter), in relation to late referral and patient demographics, are described. In addition, patient morbidity and mortality versus the type of access are discussed. CONCLUSIONS The patient described in this vignette appears to be unsuitable for the creation of a forearm AVF because of calcified distal arteries and a small cephalic vein. The risk of non-maturing autologous AVFs is high in elderly patients and this observation might justify the use of early stick grafts. High risk patients may benefit from permanent central vein catheters.
Journal of Vascular Access | 2010
Marijn Hameeteman; Aron S. Bode; Arnoud Gerardus Peppelenbosch; Frank M. van der Sande; Jan H. M. Tordoir
Background Central venous catheters (CVCs) are widely used to create a temporary or long-term access to the central venous system. A variety of treatments require a functional central venous access, including hemodialysis, administration of drugs, plasmapheresis and parenteral nutrition. The aim of this study was to evaluate the results of CVC placement performed by surgical trainees, according to a strict protocol of ultrasound-guided puncture and fluoroscopy-guided catheter insertion in a large teaching hospital in an outpatient setting. Methods Between 1 January 2006 and 31 December 2008, 539 CVCs were placed, of which 486 were primary inserted by surgical trainees. All placements were ultrasound- and fluoroscopy-guided. After every placement operators recorded type of catheter, type of anesthesia, subcutaneous tunneling, technique of insertion and complications. Results The study population consisted of 52% males. Access sites of CVCs were the internal jugular vein (91%), subclavian vein (5%) and other veins (3%). Technical success rate was 96.5%. Complication rate was 8.4%, of which 93% were arterial punctures. Pneumothorax occurred in three patients. Conclusions CVC placement by surgical trainees is a safe procedure when using a strict protocol of ultrasound-guided vessel puncture and fluoroscopic-guided catheter placement.
European Journal of Vascular and Endovascular Surgery | 2010
Jan H. M. Tordoir; M.M. van Loon; Noud Peppelenbosch; Aron S. Bode; M. Poeze; F.M. van der Sande
OBJECTIVE Successful access cannulation is of utmost importance for adequate hemodialysis treatment. Upper arm fistulae, obesity and deep or tortuous veins may impair needling and can cause significant complications and inconvenience for the patient. In the ultimate case, cannulation problems lead to temporary central vein catheter use for dialysis or even to irreversible access loss. Surgical access revision may enhance successful cannulation. METHODS A systematic literature review of all publications related to hemodialysis vascular access, cannulation complications and treatment was performed. RESULTS A total of 384 publications were identified, of which only 17 were related to treatment of cannulation complications in large patient populations. The clinical success rate of surgical intervention with vein elevation or transposition ranges from 85% to 91%. The 1-year primary and secondary patencies are 60% and 71%, respectively. Lipectomy results in an initial success rate of 100% with a primary and secondary patency of 71% and 98%, respectively, after 1 year of follow-up. CONCLUSION Surgical revision to improve hemodialysis vascular access cannulation has a high clinical success rate with good long-term patency.